Infographic | January 14, 2019

Most Difficult Aspects Of Biosimilar Manufacturing

Source: ISR Reports

By ISR Reports

In Q4, 2017 ISR asked 109 respondents who are responsible for outsourcing biologic API to hypothesize what would be the most difficult aspect of manufacturing a biosimilar. The greatest perceived challenges are to manufacture a product that is within the bioequivalent range and the reproducibility of the manufacturing process, each with 19% of respondents’ votes.

access the Infographic!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

ISR Reports